Adhesive transdermal dosage layer

Details Adhesive transdermal dosage layer Adhesive transdermal dosage layer

A - Human Necessities

61

F

167/159

A61F 13/02 (2006.01) A61L 15/06 (1985.01)

Patent

CA 1269326

ABSTRACT OF THE DISCLOSURE An adhesive bilayer transdermal dosage system capable of sustained release of a pharmaceutically active drug to the skin of a human patient having a first component layer which is a pharmaceutically active drug-containing essentially planar sheet of an at least partially cross-linked acrylic adhesive. The planar sheet is formed of a flexible self-supporting cross-linked acrylate of sufficient adhesivity, durability and strength whereby intimate diffusional contact with the skin of the patient is maintained for a period of at least about 24 hours without destruction of the physical integrity of the sheet. The sheet is capable of retaining, dispersed therein, sufficient pharmaceutically active drug to deliver to the skin a pharmaceutically effective amount of the drug over a 24-hour period without dissolution of the at least partially cross-linked acrylic adhesive. The system also contains a second component layer intimately adhered to one side of the first component layer. The second component layer is resistant to the passage of the pharmaceutically active drug from the first component layer. Methods for making the first component layer and dosage system are also disclosed.

488925

Affiliated with

Also associated with

Rating

Adhesive transdermal dosage layer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adhesive transdermal dosage layer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adhesive transdermal dosage layer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1270596